The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

cold reality

Forums General Melanoma Community cold reality

  • Post
Viewing 0 reply threads
  • Replies
      ed williams
        HI tkoss, I fail to see how this relates to melanoma patients.
            Really, Ed? What about people scheduled for infusions? Or upcoming surgeries/radiation, etc? What about just normal blood work — with compromised immune systems just going into a lab could be a real problem.
              Immunotherapy strengthens the immune system. Going to a clinic may expose a person to more risk of catching covid-19 than staying home does. However, the stage 4 melanoma death rate is much higher than the covid-19 death rate. When I received an infusion of Opdivo on April 1, receptionists and nurses wore face masks.
        Viewing 0 reply threads
        • You must be logged in to reply to this topic.
        About the MRF Patient Forum

        The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

        The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

        Popular Topics